Comments on: Consumer Reports Rips Sally Field http://dtcperspectives.com/blog/?p=123 DTC Perspectives, Inc. CEO Bob Ehrlich shares his thoughts each week about current happenings and trends in DTC Marketing Thu, 09 Sep 2010 01:10:39 +0000 http://wordpress.org/?v=2.3.1 By: Consumer Reports Rips Sally Field « Pharma Marketer http://dtcperspectives.com/blog/?p=123#comment-2517 Consumer Reports Rips Sally Field « Pharma Marketer Tue, 19 May 2009 23:36:57 +0000 http://dtcperspectives.com/blog/?p=123#comment-2517 [...] Read the original article at DTC-In-Perpsective - Consumer Reports Rips Sally Field [...] […] Read the original article at DTC-In-Perpsective - Consumer Reports Rips Sally Field […]

]]> By: Ellen Hoenig http://dtcperspectives.com/blog/?p=123#comment-2506 Ellen Hoenig Sun, 03 May 2009 16:08:50 +0000 http://dtcperspectives.com/blog/?p=123#comment-2506 Agree! Advertising is meant to educate and sell- Through the use of a very effective spokesperson, especially for this target, Boniva is providing to some, a significant choice for women--let the consumer and their doctor decide if the one month dosing is signifcantly advantageous vs the incremental cost. If the one month dosing translates to broader use and better adherence, it may well be worth the extra cost and save the healthcare system sizeable dollars by reducing the number of hip fractures going forward... (The National Osteoporosis Foundation in the USA reported that by 2010, about 12 million people over the age of 50 are expected to have osteoporosis and another 40 million to have low bone mass. In 2005 in the USA, there were predicted over 2 million fractures costing $17 billion.) Agree! Advertising is meant to educate and sell-
Through the use of a very effective spokesperson, especially for this target, Boniva is providing to some, a significant choice for women–let the consumer and their doctor decide if the one month dosing is signifcantly advantageous vs the incremental cost. If the one month dosing translates to broader use and better adherence, it may well be worth the extra cost and save the healthcare system sizeable dollars by reducing the number of hip fractures going forward…

(The National Osteoporosis Foundation in the USA reported that by 2010, about 12 million people over the age of 50 are expected to have osteoporosis and another 40 million to have low bone mass. In 2005 in the USA, there were predicted over 2 million fractures costing $17 billion.)

]]>